Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
The reconstitution of a complex microenvironment on microfluidic chips is one of the cornerstones to demonstrate the improved flexibility of these devices with respect to macroscale in vitro approaches. In this work, we realised an on-chip model to investigate the interactions between cancer and immune system. To this end, we exploited mice deficient (Knock Out, KO) for interferon regulatory factor 8 (IRF-8), a transcription factor essential for the induction of competent immune responses, to investigate how IRF-8 gene expression contributes to regulate immune and melanoma cells crosstalk. In vivo, IRF-8 KO mice are highly permissive to B16 melanoma growth due to failure of immune cells to properly exert immunosurveillance. B16 cells and immune cells isolated from the spleen of wild type (WT) and IRF-8 KO mice were co-cultured for one week in a PDMS platform and monitored by fluorescence microscopy and time-lapse recordings. We observed that WT spleen cells migrated through microchannels connecting the culturing chambers towards B16 cells and tightly interacted with tumor cells, forming clusters of activation. In contrast, IRF-8 KO immune cells poorly interacted with melanoma cells. In parallel, B16 cells were more attracted towards microchannels, acquiring a more invasive behaviour in the presence of IRF-8 KO spleen cells, with respect to WT cells. Our results strongly confirm the in vivo observations and highlight the value of on-chip co-culture systems as a useful in vitro…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, they showed that immune spleen cells lacking IRF-8 do not migrate towards cancer cells, nor interact with them as efficiently as wild type immune cells[48–50], suggesting a mechanism to explain why IRF-8 knock-out cells fail to exert proper immune-surveillance leading to a heavier metastatic burden.”
From Microfluidics: A New Tool for Modeling Cancer–Immune Interactions (2016) · cites this paper as [49]
In the citing paper
“To the best of our knowledge, only a limited number of recent studies have employed microfluidics to investigate immune-cancer cell interactions[18, 48–52], possibly because microfluidic models are not yet widely available to cancer researchers.”
From Microfluidics: A New Tool for Modeling Cancer–Immune Interactions (2016) · cites this paper as [49]
Citations
Cites
1 retracted
Jazirehi, A. R., Baritaki, S., Koya, R. C., Bonavida, B., & Economou, J. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1296 · Cited by 32
RetractedThe origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Liang, C.-C., Park, A. Y., & Guan, J.-L. (2007) · Nature Protocols · doi:10.1038/nprot.2007.30 · Cited by 4,696
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder
Dalby, M. J., Gadegaard, N., Tare, R., Andar, A., Riehle, M. O., Herzyk, P., Wilkinson, C. D. W., & Oreffo, R. O. C. (2007) · Nature Materials · doi:10.1038/nmat2013 · Cited by 2,416
Soft lithography for micro- and nanoscale patterning
Qin, D., Xia, Y., & Whitesides, G. M. (2010) · Nature Protocols · doi:10.1038/nprot.2009.234 · Cited by 2,334
El-Ali, J., Sorger, P. K., & Jensen, K. F. (2006) · Nature · doi:10.1038/nature05063 · Cited by 2,102
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Geometric cues for directing the differentiation of mesenchymal stem cells
Kilian, K. A., Bugarija, B., Lahn, B. T., & Mrksich, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903269107 · Cited by 1,841
Research works printed but not linked: 8
- Khetani, 2008, Nat Biotechnol, 26
- Huh, 2010, Science, 328
- Weibel, 2007, Nature Reviews, 5, 210
- Prager-Khoutorsky, 2011, Nature Cell Biology, 13
- Ghiringhelli, Cancer Immunol Immunother, 2006
- Shahshahan, 2011, Am J Cancer Res, 1, 913
- Poste, 1982, Cancer Res, 42, 2770
- Mattei, 2009, Eur. J. Immunol., 39, S621, 10.1002/eji.200939233 · DOI · Paper page
Cited by
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment
Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825
Ahmed, N., & Stenvers, K. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00256 · Cited by 482
“These studies, even though not directly related to CAFs in the ascites of ovarian cancer patients implicate CAFs as an important modulator of promoting ovarian tumor growth.”
BackgroundMethodInfluentialChemotherapy-induced antitumor immunity requires formyl peptide receptor 1
Vacchelli, E., Ma, Y., Baracco, E. E., Sistigu, A., Enot, D. P., Pietrocola, F., Yang, H., Adjemian, S., Chaba, K., Semeraro, M., et al. (2015) · Science · doi:10.1126/science.aad0779 · Cited by 452
Self-citationRecent advances in microfluidic technologies for cell-to-cell interaction studies
Rothbauer, M., Zirath, H., & Ertl, P. (2018) · Lab on a Chip · doi:10.1039/c7lc00815e · Cited by 277
Personalized Cancer Medicine: An Organoid Approach
Aboulkheyr Es, H., Montazeri, L., Aref, A. R., Vosough, M., & Baharvand, H. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2017.12.005 · Cited by 275
Bertani, F. R., Mozetic, P., Fioramonti, M., Iuliani, M., Ribelli, G., Pantano, F., Santini, D., Tonini, G., Trombetta, M., Businaro, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08121-8 · Cited by 234
Self-citationMicrofluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Microfluidics: A New Tool for Modeling Cancer–Immune Interactions
Boussommier-Calleja, A., Li, R., Chen, M. B., Wong, S. C., & Kamm, R. D. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2015.12.003 · Cited by 224
Trujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
Nguyen, M., De Ninno, A., Mencattini, A., Mermet-Meillon, F., Fornabaio, G., Evans, S. S., Cossutta, M., Khira, Y., Han, W., Sirven, P., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.12.015 · Cited by 184
“In particular, our recent papers (Businaro et al., 2013; Parlato et al., 2017; Vacchelli et al., 2015) demonstrated how powerful these devices are in monitoring cancer-immune interactions.”
BackgroundSelf-citationParlato, S., De Ninno, A., Molfetta, R., Toschi, E., Salerno, D., Mencattini, A., Romagnoli, G., Fragale, A., Roccazzello, L., Buoncervello, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01013-x · Cited by 181
Self-citationEngineering 3D Hydrogels for Personalized In Vitro Human Tissue Models
Liaw, C., Ji, S., & Guvendiren, M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701165 · Cited by 170
The Tumor Microenvironment: A Pitch for Multiple Players
Schiavoni, G., Gabriele, L., & Mattei, F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00090 · Cited by 147
“Recently, a simple cell-on-chip approach has been developed to investigate the crosstalk between two complex biological systems, such as immune system and cancer (Businaro et al., 2013).”
BackgroundMethodSelf-citationPatient-Derived Organoids for Precision Cancer Immunotherapy
Grönholm, M., Feodoroff, M., Antignani, G., Martins, B., Hamdan, F., & Cerullo, V. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4026 · Cited by 146
“Microfluidics systems have also successfully been used to study the migration of immune cells and their cross-talk and interaction with tumor cells (37).”
MethodTumor-on-chip modeling of organ-specific cancer and metastasis
Piccolo, N. D., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 139
3D models in the new era of immune oncology: focus on T cells, CAF and ECM
Modugno, F. D., Colosi, C., Trono, P., Antonacci, G., Ruocco, G., & Nisticò, P. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1086-2 · Cited by 121
Zhang, J., Tavakoli, H., Ma, L., Li, X., Han, L., & Li, X. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114365 · Cited by 114
Multiphase microfluidic synthesis of micro- and nanostructures for pharmaceutical applications
Ran, R., Sun, Q., Baby, T., Wibowo, D., Middelberg, A. P. J., & Zhao, C. (2017) · Chemical Engineering Science · doi:10.1016/j.ces.2017.01.008 · Cited by 110
Lugo-Cintrón, K. M., Gong, M. M., Ayuso, J. M., Tomko, L. A., Beebe, D. J., Virumbrales-Muñoz, M., & Ponik, S. M. (2020) · Cancers · doi:10.3390/cancers12051173 · Cited by 103
“In the context of breast cancer migration, microfluidic models have been developed to co-culture cancer cells with components, such as blood vessels [34], lymphatic vessels [35] and immune cells [36].”
MethodMicrofluidic single-cell analysis for systems immunology
Junkin, M., & Tay, S. (2014) · Lab on a Chip · doi:10.1039/c3lc51182k · Cited by 96
Engineering approaches for studying immune-tumor cell interactions and immunotherapy
Shelton, S. E., Nguyen, H. T., Barbie, D. A., & Kamm, R. D. (2021) · iScience · doi:10.1016/j.isci.2020.101985 · Cited by 93
3D cancer models: One step closer to in vitro human studies
Manduca, N., Maccafeo, E., Maria, R. D., Sistigu, A., & Musella, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175503 · Cited by 108
Organs on chip approach: a tool to evaluate cancer -immune cells interactions
Biselli, E., Agliari, E., Barra, A., Bertani, F. R., Gerardino, A., De Ninno, A., Mencattini, A., Di Giuseppe, D., Mattei, F., Schiavoni, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13070-3 · Cited by 91
Self-citationCancer-driven dynamics of immune cells in a microfluidic environment
Agliari, E., Biselli, E., De Ninno, A., Schiavoni, G., Gabriele, L., Gerardino, A., Mattei, F., Barra, A., & Businaro, L. (2014) · Scientific Reports · doi:10.1038/srep06639 · Cited by 91
Self-citationAndreone, S., Spadaro, F., Buccione, C., Mancini, J., Tinari, A., Sestili, P., Gambardella, A. R., Lucarini, V., Ziccheddu, G., Parolini, I., et al. (2019) · Cancers · doi:10.3390/cancers11111664 · Cited by 102
“Interaction times between eosinophils and tumor cells were calculated, as previously described [29].”
MethodSelf-citationOrganoid Models for Precision Cancer Immunotherapy
Sun, C., Lan, H., Fang, X., Yang, X., & Jin, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.770465 · Cited by 106
Communication and the emergence of collective behavior in living organisms: a quantum approach
Bischof, M., & Del Giudice, E. (2013) · Molecular Biology International · doi:10.1155/2013/987549 · Cited by 86
Lagus, T. P., & Jon, F. (2013) · RSC Advances · doi:10.1039/c3ra43624a · Cited by 86
Microfluidic co-culture system for cancer migratory analysis and anti-metastatic drugs screening
Mi, S., Du, Z., Xu, Y., Wu, Z., Qian, X., Zhang, M., & Sun, W. (2016) · Scientific Reports · doi:10.1038/srep35544 · Cited by 86
“…based on microfluidic devices, and some scholars have established co-culture tumour models in microfluidic devices to solely study cancer cell migration 11,27 , only a few studies have focused on the interaction between cells and studied the role of normal cells in breast cancer migration 10,28 .”
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Maulana, T. I., Kromidas, E., Wallstabe, L., Cipriano, M., Alb, M., Zaupa, C., Hudecek, M., Fogal, B., & Loskill, P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.015 · Cited by 91
Lucarini, V., Buccione, C., Ziccheddu, G., Peschiaroli, F., Sestili, P., Puglisi, R., Mattia, G., Zanetti, C., Parolini, I., Bracci, L., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.024 · Cited by 77
“…approach, a microfluidics-based technology recently described in our laboratory as a reliable in vivo-like system for investigating the crosstalk between immune cells and cancerous cells (BoussommierCalleja et al., 2016; Businaro et al., 2013; Mattei et al., 2014; Vacchelli et al., 2015).”
BackgroundMethodInfluentialSelf-citationMimicking Human Pathophysiology in Organ‐on‐Chip Devices
Yeşil-Çeliktaş, Ö., Hassan, S., Miri, A. K., Maharjan, S., Al‐kharboosh, R., Quiñones‐Hinojosa, A., & Zhang, Y. S. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800109 · Cited by 80
Al-Samadi, A., Poor, B., Tuomainen, K., Liu, V., Hyytiäinen, A., Sulymanova, I., Mesimaki, K., Wilkman, T., Mäkitie, A., Saavalainen, P., et al. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111508 · Cited by 63
Electro-responsive hydrogel-based microfluidic actuator platform for photothermal therapy
Ha, J. H., Shin, H. H., Choi, H. W., Lim, J. H., Mo, S. J., Ahrberg, C. D., Lee, J. M., & Chung, B. G. (2020) · Lab on a Chip · doi:10.1039/d0lc00458h · Cited by 74
A bladder cancer microenvironment simulation system based on a microfluidic co-culture model
Liu, P.-F., Cao, Y.-W., Zhang, S.-D., Zhao, Y., Liu, X.-G., Shi, H.-Q., Hu, K.-Y., Zhu, G.-Q., Ma, B., & Niu, H.-T. (2015) · Oncotarget · doi:10.18632/oncotarget.6070 · Cited by 68
Kumar, V., & Varghese, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801198 · Cited by 76
Tumor-on-a-chip platforms to study cancer–immune system crosstalk in the era of immunotherapy
Parlato, S., Grisanti, G., Sinibaldi, G., Peruzzi, G., Casciola, C. M., & Gabriele, L. (2020) · Lab on a Chip · doi:10.1039/d0lc00799d · Cited by 71
Self-citationBridging the gap: microfluidic devices for short and long distance cell–cell communication
Vu, T. Q., de Castro, R. M. B., & Qin, L. (2017) · Lab on a Chip · doi:10.1039/c6lc01367h · Cited by 63
Marzagalli, M., Pelizzoni, G., Fedi, A., Vitale, C., Fontana, F., Bruno, S., Poggi, A. D., Dondero, A., Aiello, M., Castriconi, R., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.945149 · Cited by 70
“However, most of these tumor-on-chip are used either in static conditions (Hsu et al., 2012; Businaro et al., 2013; Parlato et al., 2017; Pavesi et al., 2017; Lee et al., 2018; Guo et al., 2019; Um et al., 2019; Yu et al., 2019; Ren et al., 2020; Ayuso et al., 2021), or through simple gravity-driven flow (Song et al.”
Microfluidics for research and applications in oncology
Chaudhuri, P. K., Warkiani, M. E., Jing, T., Kenry, K., & Lim, C. T. (2015) · The Analyst · doi:10.1039/c5an00382b · Cited by 66
A 3D Microfluidic Model to Recapitulate Cancer Cell Migration and Invasion
Toh, Y.-C., Raja, A., Yu, H., & Van Noort, D. (2018) · Bioengineering · doi:10.3390/bioengineering5020029 · Cited by 57
“Microfluidic cancer migration models also allow the application of chemo-attractant gradients [16,17], improve imaging resolution [18] and can look at interaction with other cells [19,20].”
BackgroundInvestigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics
Sreepadmanabh, M., & Toley, B. J. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.009 · Cited by 60
Mattei, F., Schiavoni, G., De Ninno, A., Lucarini, V., Sestili, P., Sistigu, A., Fragale, A., Sanchez, M., Spada, M., Gerardino, A., et al. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2014.891677 · Cited by 57
“Briefly, an ROI plug-in was used to measure the maximum distance reached by the tumor cells (with respect to microchannel borders) inside the splenocyte chamber (Businaro et al., 2013).”
MethodSelf-citationDriver, R., & Mishra, S. (2022) · BioChip Journal · doi:10.1007/s13206-022-00087-8 · Cited by 69
“Businaro [41] developed a microfluidic device using carcinoma and immune cells and successfully simulated previously known in-vivo interactions, and could be used as a tool to investigate further and expand knowledge on these interactions.”
MethodEmerging trends in the methodology of environmental toxicology: 3D cell culture and its applications
Wang, H., Xu, T., & Yin, D. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159501 · Cited by 61
Chiarello, F., & Castellano, M. G. (2016) · International Journal of Game-Based Learning · doi:10.4018/ijgbl.2016040101 · Cited by 63
Santo, R. D., Romanò, S., Mazzini, A., Jovanović, S., Nocca, G., Campi, G., Papi, M., Spirito, M. D., Giacinto, F. D., & Ciasca, G. (2021) · Nanomaterials · doi:10.3390/nano11061476 · Cited by 56
Self-citationMicrofluidic technologies for immunotherapy studies on solid tumours
Paterson, K., Zanivan, S. R., Glasspool, R. M., Coffelt, S. B., & Zagnoni, M. (2021) · Lab on a Chip · doi:10.1039/d0lc01305f · Cited by 54
Liu, Y., Gill, E., & Huang, Y. Y. S. (2017) · Future Science OA · doi:10.4155/fsoa-2016-0084 · Cited by 51
Microfluidics for Cancer Nanomedicine: From Fabrication to Evaluation
Zhang, H., Zhu, Y., & Shen, Y. (2018) · Small · doi:10.1002/smll.201800360 · Cited by 49
Oncoimmunology Meets Organs-on-Chip
Mattei, F., Andreone, S., Mencattini, A., Ninno, A. D., Businaro, L., Martinelli, E., & Schiavoni, G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.627454 · Cited by 51
“In a study investigating the crosstalk between immune cells and cancer cells, Businaro and co-Workers successfully attempted to investigate on the mutual behavior of melanoma and immune cells (Businaro et al., 2013).”
BackgroundSelf-citationCell migration in microengineered tumor environments
Um, E., Oh, J. M., Granick, S., & Cho, Y. (2017) · Lab on a Chip · doi:10.1039/c7lc00555e · Cited by 47
Comes, M. C., Casti, P., Mencattini, A., Giuseppe, D. D., Mermet‐Meillon, F., Ninno, A. D., Parrini, M. C., Businaro, L., Natale, C. D., & Martinelli, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-42475-5 · Cited by 45
Self-citationLiving Cell Microarrays: An Overview of Concepts
Jonczyk, R., Kurth, T., Lavrentieva, A. V., Walter, J., Scheper, T. H., & Stahl, F. (2016) · Microarrays · doi:10.3390/microarrays5020011 · Cited by 54
“[180] have utilized such a system to investigate the cross talk between cancer and immune cells.”
BackgroundMicrofluidics in Malignant Glioma Research and Precision Medicine
Logun, M. T., Zhao, W., Mao, L., & Karumbaiah, L. (2018) · Advanced Biosystems · doi:10.1002/adbi.201700221 · Cited by 48
Cascarano, P., Comes, M. C., Mencattini, A., Parrini, M. C., Piccolomini, E. L., & Martinelli, E. (2021) · Medical Image Analysis · doi:10.1016/j.media.2021.102124 · Cited by 45
Cancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 52
Ravi, K., Manoharan, T. J. M., Wang, K.-C., Pockaj, B. A., & Nikkhah, M. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122428 · Cited by 46
Ringquist, R., Ghoshal, D., Jain, R., & Roy, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114003 · Cited by 40
Microfluidics for cell-cell interactions: A review
Li, R., Lv, X., Zhang, X., Saeed, O., & Deng, Y. (2015) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-015-1550-2 · Cited by 44
“[37], the chip was designed to observe the interaction between cancer and immune cells.”
BackgroundMencattini, A., Mattei, F., Schiavoni, G., Gerardino, A., Businaro, L., Natale, C. D., & Martinelli, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00100 · Cited by 40
Self-citationMonitoring Dynamic Interactions of Tumor Cells with Tissue and Immune Cells in a Lab-on-a-Chip
Charwat, V., Rothbauer, M., Tedde, S. F., Hayden, O., Bosch, J. J., Müellner, P., Hainberger, R., & Ertl, P. (2013) · Analytical Chemistry · doi:10.1021/ac4033406 · Cited by 42
Bersini, S., Miermont, A., Pavesi, A., Kamm, R. D., Thiery, J. P., Moretti, M., & Adriani, G. (2018) · Oncotarget · doi:10.18632/oncotarget.26306 · Cited by 38
“These models also present the advantage - compared to standard in vitro or in vivo studies - to visualize and quantify the interactions of multiple cell types, either in 2D [23] or 3D [24–27].”
Organoids Provide an Important Window on Inflammation in Cancer
Baker, K. (2018) · Cancers · doi:10.3390/cancers10050151 · Cited by 41
“also used a microfluidics device to identify IRF8 as a critical driver of immune cell trafficking towards tumors [129,130].”
MethodPappas, D. (2015) · The Analyst · doi:10.1039/c5an01778e · Cited by 32
Engineered fluidic systems to understand lymphatic cancer metastasis
Greenlee, J. D., & King, M. R. (2020) · Biomicrofluidics · doi:10.1063/1.5133970 · Cited by 31
Amadio, S., Ninno, A. D., Montilli, C., Businaro, L., Gerardino, A., & Volonté, C. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-121 · Cited by 30
“In order to prove if morphological transition affects baseline motility of primary microglia, we performed timelapse recording on artificial microfluidic substrates with controlled characteristics (chemical composition, shape, dimensions, softness) [16].”
Self-citationSukei, T., Palma, E., & Urbani, L. (2021) · Cancers · doi:10.3390/cancers13215586 · Cited by 32
Comes, M. C., Filippi, J., Mencattini, A., Casti, P., Cerrato, G., Sauvat, A., Vacchelli, E., Ninno, A. D., Giuseppe, D. D., D’Orazio, M., et al. (2020) · Neural Computing and Applications · doi:10.1007/s00521-020-05226-6 · Cited by 28
Self-citationAzizipour, N., Avazpour, R., Weber, M. H., Sawan, M., Ajji, A., & Rosenzweig, D. H. (2022) · Micromachines · doi:10.3390/mi13040587 · Cited by 27
“They often lack spatiotemporal chemical gradients [10] and three-dimensional (3D) cell–cell [11,12] and cell–extracellular matrix (ECM) interactions [13], which are all essential to maintain cellular functions [7] and define cell phenotypes [14,15].”
BackgroundMaking In Vitro Tumor Models Whole Again
Wu, K. Z., Adine, C., Mitriashkin, A., Aw, B. J. J., Iyer, N. G., & Fong, E. L. S. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202279 · Cited by 25
Analysis of Leukocyte Behaviors on Microfluidic Chips
Liu, Y., Yang, Q., Cao, L., & Xu, F. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801406 · Cited by 22
Supplementary Materials and Methods
Groenendijk, F. H., Zwart, W. T., Floore, A. N., Akbari, S., & Bernards, R. (2013) · Cited by 22
Organ-on-a-chip: Quo vademus? Applications and regulatory status
Mendes, M., Morais, A. S., Carlos, A., Sousa, J., Pais, A. A. C. C., Mihaila, S. M., & Vitorino, C. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114507 · Cited by 24
Bretti, G., Ninno, A. D., Natalini, R., Peri, D., & Roselli, N. (2021) · Axioms · doi:10.3390/axioms10040243 · Cited by 24
“In this framework, several studies [1,7,8] were conducted on immunocompetent cancer-onchips to assess the effects of therapeutic drugs on TCs and on the possible reactions of the”
BackgroundMethodInfluentialAdvancements in 3D In Vitro Models for Colorectal Cancer
Vitale, S., Calapà, F., Colonna, F., Luongo, F., Biffoni, M., Maria, R. D., & Fiori, M. E. (2024) · Advanced Science · doi:10.1002/advs.202405084 · Cited by 23
Electrospinning and microfluidics
Giannitelli, S. M., Costantini, M., Basoli, F., Trombetta, M., & Rainer, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101745-6.00008-6 · Cited by 23
“between different cell types [57,58], cell response to specific active compounds, biomolecules, or nanoparticles [59,60], etc.”
BackgroundIn vitro models as tools for screening treatment options of head and neck cancer
Seliger, B., Al‐Samadi, A., Yang, B., Salo, T. A., & Wickenhauser, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.971726 · Cited by 23
Advancements in melanoma cancer metastasis models
Melo, L. M. N., Kumar, S., Riess, V., Szylo, K. J., Eisenburger, R. T., Schadendorf, D., Ubellacker, J. M., & Tasdogan, A. (2022) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13078 · Cited by 24
“Studies using microfluidic chips have shown the interaction between spleen- derived murine immune cells and melanoma cells (Agliari et al., 2014; Businaro et al., 2013; Mattei et al., 2014).”
BackgroundZhou, L., Liu, L., Chang, M. A., Ma, C., Chen, W., & Chen, P. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115064 · Cited by 22
Li, D., Huang, P., Xia, L., Leng, W., & Qin, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111836 · Cited by 24
Ciasca, G., Mazzini, A., Sassun, T. E., Nardini, M., Minelli, E., Papi, M., Palmieri, V., & Spirito, M. D. (2019) · Condensed Matter · doi:10.3390/condmat4020058 · Cited by 21
Self-citationBayona, C., Olaizola‐Rodrigo, C., Sharko, V., Ashrafi, M., del Barrio, J., Doblaré, M., Monge, R., Ochoa, I., & Oliván, S. (2025) · Small · doi:10.1002/smll.202409229 · Cited by 23
Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold
Hu, L., Yang, X. F., Lan, H., Fang, X., Chen, X., & Jin, K. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112858 · Cited by 22
Kadilak, A. L., Rehaag, J. C., Harrington, C. A., & Shor, L. (2017) · Biomicrofluidics · doi:10.1063/1.5003477 · Cited by 18
Microfluidic Technologies in Advancing Cancer Research
Ajikumar, A., & Lei, K. F. (2024) · Micromachines · doi:10.3390/mi15121444 · Cited by 23
From simplicity to complexity in current melanoma models
Michielon, E., de Gruijl, T. D., & Gibbs, S. (2022) · Experimental Dermatology · doi:10.1111/exd.14675 · Cited by 19
Ninno, A. D., Bertani, F. R., Gerardino, A., Schiavoni, G., Musella, M., Galassi, C., Mattei, F., Sistigu, A., & Businaro, L. (2021) · Journal of Visualized Experiments · doi:10.3791/61895 · Cited by 19
Self-citationLi, Y., Fan, H., Ding, J., Xu, J., Liu, C., & Wang, H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.969723 · Cited by 19
“(Businaro et al., 2013) with permission from The Royal Society of Chemistry.”
BackgroundMethodImmature dendritic cells navigate microscopic mazes to find tumor cells
Um, E., Oh, J. M., Park, J., Song, T., Kim, T.-E., Choi, Y., Shin, C., Kolygina, D. V., Jeon, J., Grzybowski, B. A., et al. (2019) · Lab on a Chip · doi:10.1039/c9lc00150f · Cited by 15
A roadmap for translational cancer glycoimmunology at single cell resolution
Peixoto, A., Miranda, A., Santos, L. L., & Ferreira, J. A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02335-z · Cited by 16
Bioinspired Engineering of Organ-on-Chip Devices
Wang, L., Li, Z., Xu, C., & Qin, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9791-2_13 · Cited by 14
Rajan, S. A. P., Skardal, A., & Hall, A. R. (2020) · Advanced Biosystems · doi:10.1002/adbi.201900273 · Cited by 14
Mass-Preserving Approximation of a Chemotaxis Multi-Domain Transmission Model for Microfluidic Chips
Braun, E. C., Bretti, G., & Natalini, R. (2021) · Mathematics · doi:10.3390/math9060688 · Cited by 18
Advances in 3D Vascularized Tumor-on-a-Chip Technology
Jung, S., Jo, H., Hyung, S., & Jeon, N. L. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_9 · Cited by 13
Preclinical models for development of immune–oncology therapies
Wang, Y., Shelton, S. E., Kastrunes, G. M., Barbie, D. A., Freeman, G. J., & Marasco, W. A. (2022) · Immuno Oncology Insights · doi:10.18609/ioi.2022.41 · Cited by 18
Advanced in vitro models for renal cell carcinoma therapy design
Mieville, V., Griffioen, A. W., Benamran, D. A., & Nowak-Sliwinska, P. M. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188942 · Cited by 17
Zhang, Z., Chen, D., Li, Z., Liu, Z., Yan, L., & Xu, Z. (2020) · BioMed Research International · doi:10.1155/2020/6034670 · Cited by 11
“In this study, we integrated the gene expression data associated with extracellular matrix and immune response and obtained a great deal of DEGs with prognostic significance to improve the prediction of BLCA clinical outcomes and explore the interplay between tumor cells and the microenvironment [29, 52, 53].”
MethodBiochips—New Platforms for Cell‐Based Immunological Assays
Shao, N., & Qin, L. (2017) · Small Methods · doi:10.1002/smtd.201700254 · Cited by 12
Metadata
- Authors
- Businaro, L., De Ninno, A., Schiavoni, G., Lucarini, V., Ciasca, G., Gerardino, A., Belardelli, F., Gabriele, L., & Mattei, F.
- Affiliations
- National Research Council (IT)
- Istituto Superiore di Sanità (IT)
- Corresponding author
- Businaro, Luca
- Mattei, Fabrizio
- ORCID
- Venue
- Lab Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 13
- Issue
- 2
- Pages
- 229-239
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2033651938
- Cited by
- 162
- References
- 52
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 14 · 2023: 11 · 2022: 17 · 2021: 18 · 2020: 11 · 2019: 14 · 2018: 18 · 2017: 12 · 2016: 10 · 2015: 7 · 2014: 4 · 2013: 8
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
- Keywords
- IRF8, B16 melanoma, tumor surveillance, microfluidics, PDMS microchannel, leukocyte migration, tumor invasion, splenocytes, anti-tumor therapy
- MeSH terms
- Interferon Regulatory Factor-8, Animals, Cell Communication, Cell Movement, Cells, Cultured, Flow Cytometry, Melanoma, Mice, Inbred C57BL, Microscopy, Fluorescence, Spleen, Stress, Physiological, Mice, Knockout, Coculture Techniques, Microfluidic Analytical Techniques, Interferon Regulatory Factors, Mice, Time-Lapse Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.